2 March 2017

Morning Live Updates ; Market Opens at New 52-Week High; Sensex Up 150 pts

Today Live Equity benchmarks started off session at fresh 52-week high on Thursday, with the Nifty March futures hitting 9000 level, backed by banks, auto, technology and metals stocks. The 30-share BSE Sensex was up 148.09 points at 29132.58 and the 50-share NSE Nifty gained 41.90 points at 8987.70. About 673 shares advanced against 106 declining shares on the BSE. 

For Free trial visit us @ 
Give a Missed Call at "830-630-830-8"    

Tata Motors, ICICI Bank, Wipro, Bajaj Auto, GAIL, Hindalco and Tata Motors (DVR) were early gainers while Dr Reddy's Labs and Coal India were under pressure. The Indian rupee gained by 8 paise at 66.75 per dollar versus 66.83 Wednesday. Tirthankar Patnaik of Mizuho Bank says he expects the USD-INR to range between 66.50-67.50/dollar in the near term with the State election results on March 11 crucial for its continued strength. 

The dollar hit a seven-week high after hawkish comments from two Federal Reserve officials increased expectations that the US Central Bank is closer to raising interest rates. Futures traders are now pricing in a 69 percent chance of a Fed hike in March, up from 35 percent on Tuesday. Asia markets traded mostly higher, tracking gains in the US where the Dow Jones industrial average closed above 21,000 on the back of President Donald Trump's speech to lawmakers.

1 March 2017

Sensex, Nifty, Midcap Hold Morning Gains; Tata Motors Falls

Equity benchmarks as well as broader markets maintained morning gains, driven by banking & financials, FMCG and pharma stocks after Q3 GDP data surprised street. 
For details visit us @  
Give a Missed Call at "830-630-830-8"

The 30-share BSE Sensex gained 194.54 points at 28937.86 and the 50share NSE Nifty rose 51.75 points to 8931.35 while the Nifty Midcap and Smallcap indices were up around 0.6 percent. About 1593 shares advanced against 936 declining shares on the BSE.

India's real gross domestic product (GDP) beat consensus estimates, growing 7 percent YoY in Q3FY17 as private consumption grew at the fastest pace in 17 quarters. Tata Motors fell over a percent ahead of February sales data due later today. Maruti Suzuki was up 0.2 percent after sales in the month gone by grew 11 percent while Eicher Motors fell 0.6 percent as Royal Enfield sales missed analysts' expectations, growing 19 percent year-on-year. 

Index heavyweights HDFC, Infosys, ITC and ICICI Bank continued to support the market, up 1-2 percent. Gold fell today as the dollar strengthened on hawkish comments overnight from US Federal Reserve officials, while an eagerly awaited speech by US President Donald Trump contained few specifics or surprises.

29 November 2016

Stock Market Tips - Top 5 Stocks in Focus Today

Check out the companies which will be in focus during trade today based on recent and latest news developments. 
Sensex, Nifty may stay flat; Idea, Tata Steel in focus
For details visit us @  
Give a Missed Call at "830-630-830-8"
Tata Steel: Tata Steel UK has signed a letter of intent with Liberty House to sell its UK speciality steel business, the company said in a statement on Monday. The deal, which also covers several South-Yorkshire based assets, is being pegged at an enterprise value of £100 million.

Sun Pharma: Sun Pharma launched BromSite solution, marked for treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery, in the US market.

Oil India: The company has posted a net profit of Rs 580 crore for the quarter ended September 30, 2016 as compared to Rs 706 crore for the quarter ended September 30, 2015.

Mahanagar Gas: Mahanagar Gas registered a net profit of Rs 102.24 crore, up 41%, against Rs 72.57 crore in the corresponding quarter last year.

JSW Steel: JSW Steel has joined one of two investor groups vying to take over Italy's loss-making Ilva steel plant, as per media report.

28 November 2016

Top 5 Stocks in Focus Today: Cipla, Ashok Leyland

Check out the companies which will be in focus during trade today based on recent and latest news developments. 
Top stocks in focus today

For Free trial visit us @ 
Give a Missed Call at "830-630-830-8"
Oil India: The company will announce its Q2 numbers today.  

Cipla: Cipla Ltd is in discussions to sell Cipla Vet, its animal health division, as per media report. According to the report, the company hired global investment bank Rothschild to find potential buyers.  

Ashok Leyland: Ashok Leyland has completed the acquisition of Nissan Motor Co. Ltd.’s stake in each of the three joint ventures formed between the two companies.  

Aurobindo Pharma: Arrow Generiques SAS, the French subsidiary of Aurobindo Pharma, has signed an agreement to acquire select commercial products in France from Teva.  

BEML: Thr company reported standalone net loss narrowed to Rs 16.6 crore for the second quarter ended September 30, 2016, against that of Rs 24.6 crore in the corresponding quarter of previous fiscal. 

25 November 2016

Top 5 Stocks in Focus Today: Sun Pharma

Check out the companies which will be in focus during trade today based on recent and latest news developments.
Top stocks in focus today

Sun Pharma: The US drug regulator has found seven breaches of manufacturing standards at Sun Pharmaceutical Industries Ltd’s formulations plant in Mohali, Punjab, following a recent inspection.

Aurobindo Pharma Ltd: Aurobindo Pharma is scouting for acquisitions in Europe to gain a foothold in the market, as per media reports.

Wipro: The company has informed bourses that it has granted 5,000 Restricted Stock Units under Restricted Stock Unit Plan 2007 effective November 1, 2016 to its identified employee.

TCS: Tata Consultancy Services is rethinking how it appraises its over 3,70,000 employees after scrapping the Bell Curve model.

YES Bank: The bank announced a partnership with Gujarat State Road Transport Corporation (GSRTC) to digitise payment of bus tickets for its customers. 
For Free trial visit us @ 
Give a Missed Call at "830-630-830-8"

Top 5 Stocks in Focus Today: Sun Pharma

Check out the companies which will be in focus during trade today based on recent and latest news developments.
Top stocks in focus today

Sun Pharma: The US drug regulator has found seven breaches of manufacturing standards at Sun Pharmaceutical Industries Ltd’s formulations plant in Mohali, Punjab, following a recent inspection.

Aurobindo Pharma Ltd: Aurobindo Pharma is scouting for acquisitions in Europe to gain a foothold in the market, as per media reports.

Wipro: The company has informed bourses that it has granted 5,000 Restricted Stock Units under Restricted Stock Unit Plan 2007 effective November 1, 2016 to its identified employee.

TCS: Tata Consultancy Services is rethinking how it appraises its over 3,70,000 employees after scrapping the Bell Curve model.

YES Bank: The bank announced a partnership with Gujarat State Road Transport Corporation (GSRTC) to digitise payment of bus tickets for its customers. 
For Free trial visit us @ 
Give a Missed Call at "830-630-830-8"

24 November 2016

Top 5 Stocks in Focus Today: SBI, Tata Motors, PC Jeweller

Check out the companies which will be in focus during trade today based on recent and latest news developments.
Top stocks in focus today

For Free trial visit us @ 
Give a Missed Call at "830-630-830-8"

State Bank of India: SBI on Wednesday slashed bulk deposit rates by up to 1.9%, taking advantage of the surge in deposits following demonetisation.
  
Tata Motors: Tata Motors has called an extraordinary general meeting on December 22 to seek shareholders' approval for removing Cyrus Mistry and Nusli Wadia as directors of the company.  

PC Jeweller: The company posted a net profit of Rs 1,06.9 crore for the quarter ended September 30, 2016 as compared to Rs. 92 crore in the corresponding quarter last year.

Sun Pharma: The pharma company has entered into an agreement to acquire 85.1% of JSC Biosintez, that makes and markets pharmaceutical products in Russia and the CIS region.  

Cipla Ltd: The company is divesting its minority 16.7% stake in Chase Pharmaceuticals Corporation, to a subsidiary of Allergan Plc.